|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.42 USD | -3.64% |
|
+3.92% | +14.15% |
| 07-02 | Avid Bioservices Fiscal Q4 Loss Widens, Revenue Increases; Fiscal 2025 Revenue Outlook Set | MT |
| 07-02 | Transcript : Avid Bioservices, Inc., Q4 2024 Earnings Call, Jul 02, 2024 |
Avid Bioservices provided earnings guidance for fiscal Year 2025. For the period, the company expects revenue of $160 million to $168 million.
| 1st Jan change | Capi. | |
|---|---|---|
| +14.15% | 490M | |
| +4.57% | 96.72B | |
| +5.66% | 41.43B | |
| -12.80% | 32.7B | |
| +80.99% | 29.06B | |
| -15.53% | 15.38B | |
| -8.70% | 12.97B | |
| -12.22% | 11.36B | |
| +183.25% | 9.9B | |
| +3.60% | 8.93B |
AVID BIOSERVICES, INC. 
